249 related articles for article (PubMed ID: 28716899)
1. HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.
Song KH; Choi CH; Lee HJ; Oh SJ; Woo SR; Hong SO; Noh KH; Cho H; Chung EJ; Kim JH; Chung JY; Hewitt SM; Baek S; Lee KM; Yee C; Son M; Mao CP; Wu TC; Kim TW
Cancer Res; 2017 Sep; 77(18):5039-5053. PubMed ID: 28716899
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of HDAC1 via TCL1-pAKT-CHFR axis is a key element for NANOG-mediated multi-resistance and stem-like phenotype in immune-edited tumor cells.
Woo SR; Lee HJ; Oh SJ; Kim S; Park SH; Lee J; Song KH; Kim TW
Biochem Biophys Res Commun; 2018 Sep; 503(3):1812-1818. PubMed ID: 30060952
[TBL] [Abstract][Full Text] [Related]
3. LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells.
Kim S; Cho H; Hong SO; Oh SJ; Lee HJ; Cho E; Woo SR; Song JS; Chung JY; Son SW; Yoon SM; Jeon YM; Jeon S; Yee C; Lee KM; Hewitt SM; Kim JH; Song KH; Kim TW
Autophagy; 2021 Aug; 17(8):1978-1997. PubMed ID: 32762616
[TBL] [Abstract][Full Text] [Related]
4. HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors.
Song KH; Oh SJ; Kim S; Cho H; Lee HJ; Song JS; Chung JY; Cho E; Lee J; Jeon S; Yee C; Lee KM; Hewitt SM; Kim JH; Woo SR; Kim TW
Nat Commun; 2020 Jan; 11(1):562. PubMed ID: 31992715
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-κB activation, and promotion of cell invasion and angiogenesis.
Ding X; Xu J; Wang C; Feng Q; Wang Q; Yang Y; Lu H; Wang F; Zhu K; Li W; Yan Q; Gao SJ; Lu C
Cell Death Differ; 2019 Oct; 26(10):1970-1986. PubMed ID: 30670829
[TBL] [Abstract][Full Text] [Related]
6. ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy.
Dutta I; Dieters-Castator D; Papatzimas JW; Medina A; Schueler J; Derksen DJ; Lajoie G; Postovit LM; Siegers GM
Cancer Lett; 2021 Jan; 496():156-168. PubMed ID: 33045304
[TBL] [Abstract][Full Text] [Related]
7. BRG1 Governs Nanog Transcription in Early Mouse Embryos and Embryonic Stem Cells via Antagonism of Histone H3 Lysine 9/14 Acetylation.
Carey TS; Cao Z; Choi I; Ganguly A; Wilson CA; Paul S; Knott JG
Mol Cell Biol; 2015 Dec; 35(24):4158-69. PubMed ID: 26416882
[TBL] [Abstract][Full Text] [Related]
8. Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle.
Oh SJ; Lee HJ; Song KH; Kim S; Cho E; Lee J; Bosenberg MW; Kim TW
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35104240
[TBL] [Abstract][Full Text] [Related]
9. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
Caslini C; Hong S; Ban YJ; Chen XS; Ince TA
Oncogene; 2019 Sep; 38(39):6599-6614. PubMed ID: 31375747
[TBL] [Abstract][Full Text] [Related]
10. 1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells.
Jia Z; Zhang Y; Yan A; Wang M; Han Q; Wang K; Wang J; Qiao C; Pan Z; Chen C; Hu D; Ding X
Cell Death Dis; 2020 Aug; 11(8):670. PubMed ID: 32820157
[TBL] [Abstract][Full Text] [Related]
11. Nanog signaling in cancer promotes stem-like phenotype and immune evasion.
Noh KH; Kim BW; Song KH; Cho H; Lee YH; Kim JH; Chung JY; Kim JH; Hewitt SM; Seong SY; Mao CP; Wu TC; Kim TW
J Clin Invest; 2012 Nov; 122(11):4077-93. PubMed ID: 23093782
[TBL] [Abstract][Full Text] [Related]
12. Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.
Pathania R; Ramachandran S; Mariappan G; Thakur P; Shi H; Choi JH; Manicassamy S; Kolhe R; Prasad PD; Sharma S; Lokeshwar BL; Ganapathy V; Thangaraju M
Cancer Res; 2016 Jun; 76(11):3224-35. PubMed ID: 27197203
[TBL] [Abstract][Full Text] [Related]
13. IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
Hu H; Sun J; Wang C; Bu X; Liu X; Mao Y; Wang H
Biochem Biophys Res Commun; 2017 Apr; 485(3):643-650. PubMed ID: 28216163
[TBL] [Abstract][Full Text] [Related]
14. Role of Epigenetic Regulation by the REST/CoREST/HDAC Corepressor Complex of Moderate NANOG Expression in Chicken Primordial Germ Cells.
Jung HG; Hwang YS; Park YH; Cho HY; Rengaraj D; Han JY
Stem Cells Dev; 2018 Sep; 27(17):1215-1225. PubMed ID: 30032710
[TBL] [Abstract][Full Text] [Related]
15. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers.
Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC
Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344
[TBL] [Abstract][Full Text] [Related]
16. Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis.
Oh SJ; Cho H; Kim S; Noh KH; Song KH; Lee HJ; Woo SR; Kim S; Choi CH; Chung JY; Hewitt SM; Kim JH; Baek S; Lee KM; Yee C; Park HC; Kim TW
Cancer Res; 2018 May; 78(10):2638-2653. PubMed ID: 29437706
[TBL] [Abstract][Full Text] [Related]
17. NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59.
Son SW; Cho E; Cho H; Woo SR; Lee HJ; Oh SJ; Kim S; Kim JH; Chung EJ; Chung JY; Kim MG; Song KH; Kim TW
Sci Rep; 2022 May; 12(1):8652. PubMed ID: 35606403
[TBL] [Abstract][Full Text] [Related]
18. ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype.
Portney BA; Arad M; Gupta A; Brown RA; Khatri R; Lin PN; Hebert AM; Angster KH; Silipino LE; Meltzer WA; Taylor RJ; Zalzman M
Oncogene; 2020 Jun; 39(26):4970-4982. PubMed ID: 32507861
[TBL] [Abstract][Full Text] [Related]
19. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
[TBL] [Abstract][Full Text] [Related]
20. Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach.
Wang L; Chen G; Chen K; Ren Y; Li H; Jiang X; Jia L; Fu S; Li Y; Liu X; Wang S; Yang J; Wu C
Oncotarget; 2015; 6(12):9740-55. PubMed ID: 25762635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
